Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting
NCT07549607 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-04-24
Summary
The seladelpar registry will collect real-world data of patients with PBC diagnosis treated with seladelpar in the real-life scenario in Germany and Switzerland.
Conditions
- Primary Bilary Cirrhosis (PBC)
Sponsors & Collaborators
-
University of Leipzig
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2028-04-01
- Completion
- 2028-10-01
Countries
- Germany
- Switzerland
Study Locations
More Related Trials
-
The European NAFLD Registry
NCT04442334 ·Status: RECRUITING
-
The Detection of Small Early Liver Cancer With Natural History Follow up
NCT05534906 ·Status: RECRUITING
-
Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation
NCT05256979 ·Status: ACTIVE_NOT_RECRUITING
-
The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis
NCT06021743 ·Status: UNKNOWN
-
Study on Risk Factors and Prognosis of MASLD
NCT07433205 ·Status: COMPLETED
-
Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH
NCT05357248 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Intervention in Fatty Liver (NAFLD)
NCT03354247 ·Status: UNKNOWN ·Phase: NA
-
Advanced Fibrosis Detection for MASLD in Primary Care
NCT07159386 ·Status: RECRUITING ·Phase: NA
-
LEOPARD Prospective Validation Cohort 1
NCT06723275 ·Status: NOT_YET_RECRUITING
-
Improving Healthcare Outcomes With Early Detection of Liver Related Complications in Liver Cirrhosis Patients by Implementing a Telemedicine Care Pathway (myLIVERcoach)
NCT07376967 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia
NCT06634160 ·Status: RECRUITING
-
Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI
NCT07305324 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis
NCT07291141 ·Status: RECRUITING
-
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
NCT07051863 ·Status: RECRUITING
-
SASL Swiss Cirrhosis Cohort
NCT06092385 ·Status: RECRUITING
-
Lifestyle Modification in the Treatment of NAFLD.
NCT05816915 ·Status: RECRUITING ·Phase: NA
-
THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)
NCT04925362 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
NCT02174367 ·Status: UNKNOWN
-
Impact of Hepatitis C Virus Variability on Steatosis
NCT00843076 ·Status: TERMINATED
-
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
NCT06661655 ·Status: RECRUITING ·Phase: NA
-
International Alfapump Cohort Study
NCT04326946 ·Status: ACTIVE_NOT_RECRUITING
-
DEFINITION OF THE GENOMIC LANDSCAPE OF MASLD
NCT07249112 ·Status: RECRUITING ·Phase: NA
-
Effect of Plant-based Diets on Liver Biomarkers, Cardiometabolic Health, and Exposure to Environmental Contaminants and Endocrine Disruptors in Patients With Metabolic Liver Disease.
NCT07503431 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China
NCT03435406 ·Status: UNKNOWN
-
Complex Exploratory Study of Alcohol-Associated Hepatitis
NCT06358196 ·Status: NOT_YET_RECRUITING